Skip to content
AlternativeMed

Ancestry and Population Applicability of Genetic Findings

Why many genetic findings, especially polygenic scores and variant classifications, were built mostly on European-ancestry data and may be less accurate or less informative for other populations.

Content last updated . This page has not been medically reviewed.

The core problem

Genetic research has not studied all populations equally. Most findings used in tests today come from large studies that mostly enrolled people of European ancestry, so a result may be more accurate for some groups than for others. This page explains what studies found. It is information only and not medical advice. It does not say that ancestry decides anyone's health. "Ancestry" here describes which reference data a method was built on.

Polygenic scores

A polygenic risk score adds up the effects of many variants to estimate relative risk for a common condition. NHGRI notes that most genomic studies to date examined people of European ancestry, so data for other populations may be inadequate, and that the accuracy of these scores may only be valid and useful for European ancestry populations at this point. [1] A review in Nature Genetics concluded that available scores are several times more accurate in individuals of European ancestry than in other ancestries, and that this follows from the Eurocentric bias of genome-wide association studies. [2]

A separate analysis looked at the first decade of polygenic scoring studies (2008 to 2017). It found that 67% included only European-ancestry participants, and only 3.8% involved cohorts of African, Hispanic or Indigenous peoples. [3] The same analysis found lower predictive performance of European-derived scores in non-European samples. [3] See polygenic risk scores.

Variant classification

The same imbalance affects variant reports. In germline testing, variants from understudied ancestries have been disproportionately classified as being of uncertain significance. [4] That study also found reclassification rates differed by ancestry group. [4] Read more in variant interpretation and uncertain significance.

Ancestry tests and their reference databases

Consumer ancestry estimates compare a person's DNA to reference databases of people with known ancestry. MedlinePlus Genetics notes that different companies use different reference databases and methods, so estimates may not be consistent from one company to another. [5] It also says populations may not be equally represented in a given database, so results for some populations may be less informative than for others. [5] Results may also reflect where a family originated rather than where its members lived. [5]

What this means for wellness products

  • A "genetic health" or "gene-based wellness" report built on a score validated mostly in one ancestry group may not mean the same thing for you.
  • Claims of "personalized" accuracy are marketing claims unless the company shows performance in people like you. See claim check: personalized means better.
  • Even where a score is more accurate, it only shows relative risk and always gives probabilities, not certainties. [1]

What is being done

The authors of the Nature Genetics review said that greater diversity must be prioritized in genetic studies and that summary statistics must be publicly shared, noting that early efforts to diversify show promise. [2] Whether this will close the gap is not yet known.

Frequently asked questions

Are polygenic scores equally accurate for everyone?

No. Available scores are several times more accurate in people of European ancestry than in other ancestries. [2]

Why are non-European groups less represented?

In the first decade of polygenic scoring studies, 67% of studies had only European-ancestry participants. [3] Why this happened is beyond the scope of these studies.

Do ancestry tests from different companies give the same answer?

Not necessarily. Reference databases and methods differ, so estimates may not match. [5]

Does my ancestry change my disease risk?

This page cannot say. It describes how well certain tests were built and validated, not an individual's risk. [1]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

How to read the evidence labels

Labels used on this page: established (the imbalance in study populations), mixed (how large the gap is for each test) and insufficient evidence (whether fixing it will close the gap). The full set is explained in how we label evidence.

Safety note
Do not make medical decisions from a polygenic score or an ancestry estimate. Ask a clinician or genetic counselor how a result was validated for someone with your background.
References
  1. National Human Genome Research Institute (NIH). Polygenic Risk Scores. Read 2026-10-22.
  2. Martin AR, et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019. PMID 30926966. Read 2026-10-22.
  3. Duncan L, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019. PMID 31346163. Read 2026-10-22.
  4. Slavin TP, et al. Prospective study of cancer genetic variants: variation in rate of reclassification by ancestry. J Natl Cancer Inst. 2018. PMID 29618041. Read 2026-10-22.
  5. MedlinePlus Genetics (NIH). What is genetic ancestry testing?. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.